Skip to main content

Table 2 Preoperative, Intraoperative and postoperative patient characteristics

From: Cardiac autotransplantation and ex vivo surgical repair of giant left atrium: a case presentation

Patient/Case # 1 2 3 4
Preoperative data
 MV regurgitation (grade) Severe Severe No Severe
 MV Stenosis (grade) No No Severe No
 MV annulus (cm) 5.5 4.4 4.0 4.6
 TV regurgitation (grade) Severe Severe Moderate Moderate
 TV annulus (cm) 4.1 3.8 2.7 3.7
 LA diameter (cm) (Fig. 2) 13 17 9.2 9
 LA area (cm2) 143 221 120 81
 IVSd (cm) 12 12 10 11
 LVPWD(cm) 12 12 10 11
 LVEDd (cm) 6.8 6.0 6.2 5.1
 LVEDs (cm) 3.5 3.5 3.8 3.4
 LVEF (%) (Fig. 2) 40 40 35 45
 SPAP (mmHg) (Fig. 2) >  40 >  40 >  35 >  30
 NYHA classification IV IV IV IV
 Coronary angiography Normal Normal Normal normal
Perioperative data
 Cardiopulmonary bypass (min) 87 135 253 135
 Aorta cross-clamp time (min) 48 73 177 82
 Total operation duration (min) 215 250 338 195
 Mechanical ventilation (hours) 96 46 96 24
 ICU LOS (hours) 202 3 7 14
 Total Hospitalisation (days) 202 19 15 20
Postoperative analysis
 MV annulus (cm) 3.2 3.0 3.1 2.7
 MV regurgitation (grade) No No No No
 MV stenosis (grade) No No No No
 TV (grade) No No No mild
 LA diameter (cm) 6.5 5.6 3.5 4.7
 LA area (cm2) (Fig. 2) 42.5 36 16.8 29.8
 LVEF (%) (Fig. 2) 50 40 40 50
 Complications Fever No Mild fever No
 SPAP (mmHg) (Fig. 2) 30 30 20 20
 NYHA classificaton II I I
 Follow up (days) 214 3816 4855 249
 Postoperative Sinus rhythm duration (days) 0 364 0 5
 Intrahospital mortality (days) 214 No No No
 Cause of death Mesenteric ischemia Sepsis Malignancy
  1. MV Mitral Valve
  2. TV Tricuspid Valve
  3. LA Left Atrium
  4. IVSd Interventricular Septal Thickness at Diastole
  5. LVPWD Left ventricular posterior wall dimension
  6. LVEDd Left ventricular diastolic diameter
  7. LVESd Left ventricular systolic diameter
  8. LVEF Left Ventricular Ejection Fraction
  9. SPAP Systolic Pulmonary Arterial Pressure
  10. NYHA New York Heart Association
  11. SPAP is measured via a Swan-Ganz catheter
  12. Symbols adjacent to the patient case # correspond to the symbols used in Fig. 2 to facilitate individual analysisv